Ebitda Alterar Data
AbbVie USD 6.75B 433M 2023-09
Amgen USD 3.66B 713M 2023-12
Arrowhead Research USD -132282000 27.81M 2023-12
AstraZeneca USD 3.43B 412M 2023-09
Biogen USD 652.1M 241.8M 2023-12
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Gilead Sciences USD 2.73B 579M 2023-12
GlaxoSmithKline GBP 3.17B 729M 2023-09
Halozyme Therapeutics USD 121.73M 10.37M 2023-12
Heron Therapeutics USD -24202000 17.46M 2023-09
Incyte USD 226.99M 9.73M 2023-12
Insmed USD -159156000 23.92M 2023-12
Ionis Pharmaceuticals USD -2924000 137.16M 2023-12
J&J USD 6.46B 1.51B 2023-12
Ligand Pharmaceuticals USD 5.56M 4.01M 2023-12
Marinus Pharmaceuticals USD -31504000 192K 2023-09
Merck USD 7.51B 11.02B 2023-09
Neurocrine Biosciences USD 146.7M 68M 2023-09
Novavax USD -114711000 194.94M 2023-09
Pfizer USD 1.14B 2.05B 2023-12
PTC Therapeutics USD 88.72M 144.83M 2023-12
Roche Holding CHF 12.35B 1.92B 2023-06
Sarepta Therapeutics USD -9914000 112.81M 2023-09
Vertex Pharmaceuticals USD 1.08B 12.4M 2023-09



Enanta Pharmaceuticals - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.